XORTX Therapeutics Inc. - XRTX
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | History | New | 38,468 | 35 | 0.0% | — | 1 | +38,468 | New | Q2 2025 | Aug 14, 2025 |
| UBS Group AG | History | New | 20,790 | 18 | 0.0% | — | 2 | +20,790 | New | Q2 2025 | Aug 14, 2025 |
| NATIONAL BANK OF CANADA /FI/ | History | Added to | 3,934 | 3 | 0.0% | — | 3 | +3,760 | 2160.92% | Q2 2025 | Aug 18, 2025 |
| ROYAL BANK OF CANADA | History | New | 663 | 1 | 0.0% | — | 4 | +663 | New | Q2 2025 | Aug 14, 2025 |
| RAYMOND JAMES FINANCIAL INC | History | New | 500 | 0 | — | — | — | +500 | New | Q2 2025 | Aug 14, 2025 |
| Clearstead Advisors, LLC | History | No change | 277 | 0 | — | — | — | 0 | 0.0% | Q2 2025 | Aug 08, 2025 |